Efficacy of biogenic selenium nanoparticles against Leishmania major: In vitro and in vivo studies

Journal of Trace Elements in Medicine and Biology

Volumn 27, Issue 3, 2013, Pages 203-207

  Beheshti, Nasibeh ^a   Soflaei, Saied ^a   Shakibaie, Mojtaba ^b   Yazdi, Mohammad Hossein ^c   Ghaffarifar, Fatemeh ^a   Dalimi, Abdolhossein ^a   Shahverdi, Ahmad Reza ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti leishmanial effect; Bacillus sp. MSh 1; Biogenic selenium nanoparticle; Leishmania major

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; NANOPARTICLE; SELENIUM NANOPARTICLE; UNCLASSIFIED DRUG; METAL NANOPARTICLE; SELENIUM;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACILLUS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL ASSAY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG EFFICACY; IC 50; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LEISHMANIA MAJOR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS; ANIMAL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; MICROBIAL SENSITIVITY TEST; STRUCTURE ACTIVITY RELATION;

ANIMALIA; BACILLUS SP.; LEISHMANIA MAJOR; MUS;

ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IN VITRO TECHNIQUES; INJECTIONS, INTRAPERITONEAL; LEISHMANIA MAJOR; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; SELENIUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84879416207     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.11.002     Document Type: Article

References (31)

1. Reithinger R., Dujardin J.C., Louzir H., Pirmez C., Alexander B., Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007, 7:581-596.
2. Murray H.W., Berman J.D., Davies C.R., Saravia N.G. Advances in leishmaniasis. Lancet 2005, 366:1561-1577.
3. Santos D.O., Coutinho C.E., Madeira M.F., Bottino C.G., Vieira R.T., Nascimento S.B., et al. Leishmaniasis treatment-a challenge that remains: a review. Parasitol Res 2008, 103:1-10.
4. Kaye P.M., Aebischer T. Visceral leishmaniasis: immunology and prospects for a vaccine. Clin Microbiol Infect 2011, 17:1462-1470.
5. Davis A.J., Kedzierski L. Recent advances in antileishmanial drug development. Curr Opin Investig Drugs 2005, 6:163-169.
6. Monzote L. Antileishmanial patents antileishmanial current drugs and relevant patents. Recent Pat Antiinfect Drug Discov 2011, 6:1-26.
7. Kedzierski L., Sakthianandeswaren A., Curtis J.M., Andrews P.C., Junk P.C., Kedzierska K. Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr Med Chem 2009, 16:599-614.
8. Frézard F., Demicheli C., Ribeiro R.R. Pentavalent antimonials: new perspectives for old drugs. Molecules 2009, 14:2317-2336.
9. Mishra J., Saxena A., Singh S. Chemotherapy of leishmaniasis: past, present and future. Curr Med Chem 2007, 14:1153-1169.
10. Croft S.L., Sundar S., Fairlamb A.H. Drug resistance in leishmaniasis. Clin Microbiol Rev 2006, 19:111-126.
11. Robert J.M.H., Sabourin C., Alvarez N., Robert-Piessard S., Baut G.L., Le Pape P. Synthesis and antileishmanial activity of new imidazolidin-2-one derivatives. Eur J Med Chem 2003, 38:711-718.
12. Kappagoda S., Singh U., Blackburn B.G. Antiparasitic therapy. Mayo Clin Proc 2011, 86:561-583.
13. Mohanpuria P., Rana N.K., Yadav S.K. Biosynthesis of nanoparticles: technological concepts and future applications. J Nanopart Res 2008, 10:510-517.
14. Kubik T., Bogunia-Kubik K., Sugisaka M. Nanotechnology on duty in medical applications. Curr Pharm Biotechnol 2005, 6:17-33.
15. Tapiero H., Townsend D.M., Tew K.D. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 2003, 57:134-144.
16. Zeng H., Combs G.F. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 2008, 19:1-7.
17. Beck M.A., Levander O.A., Handy J. Selenium deficiency and viral infection. J Nutr 2003, 133:1463S-1467S.
18. Zagrodzki P. Selenium and the immune system. Postepy Hig Med Dosw 2004, 18:140-149.
19. Yang L.B., Shen Y.H., Xie A.J., Liang J.J., Zhang B.C. Synthesis of Se nanoparticles by using TSA ion and its photocatalytic application for decolorization of Congo red under UV irradiation. Mater Res Bull 2008, 43:572-582.
20. Raevskaya A.E., Stroyuk A.L., Kuchmiy S.Y., Dzhagan V.M., Zahn D.R.T., Schulze S. Annealing-induced structural transformation of gelatin-capped Se nanoparticles. Solid State Commun 2008, 145:288-292.
21. Zhang J.S., Gao X.Y., Zhang L.D., Bao Y.P. Biological effect of a nano red elemental selenium. Biofactors 2001, 15:27-38.
22. Zhang J., Wang H., Yan X., Zhang L. Comparison of short-term toxicity between Nano-Se and selenite in mice. Life Sci 2005, 76:1099-1109.
23. Zhang J., Wang X., Xu T. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice. Toxicol Sci 2007, 101:22-31.
24. Shakibaie M., Khorramizadeh M.R., Faramarzi M.A., Sabzevari O., Shahverdi A.R. Biosynthesis and recovery of selenium nanoparticles and the effects on matrix metalloproteinase-2 expression. Biotechnol Appl Biochem 2010, 56:7-15.
25. Bhattacharya D., Rajinder G. Nanotechnology and potential of microorganisms. Crit Rev Biotechnol 2005, 25:199-204.
26. Wang H., Zhang J., Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med 2007, 42:1524-1533.
27. Lobanov A.V., Gromer S., Salinas G., Gladyshev V.N. Selenium metabolism in Trypanosoma: characterization of selenoproteomes and identification of a Kinetoplastid-specific selenoprotein. Nucleic Acids Res 2006, 34:4012-4024.
28. Wlodkowic D., Telford W., Skommer J., Darzynkiewicz Z. Apoptosis and beyond: cytometry in studies of programmed cell death. Methods Cell Biol 2011, 103:55-98.
29. Chen T., Wong Y.S., Zheng W., Bai Y., Huang L. Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells. Colloids Surf B 2008, 67:26-31.
30. Hoffmann P.R., Berry M.J. The influence of selenium on immune responses. Mol Nutr Food Res 2008, 52:1273-1280.
31. Yazdi M.H., Mahdavi M., Varastehmoradi B., Faramarzi M.A., Shahverdi A.R. The immunostimulatory effect of biogenic selenium nanoparticles on the 4T1 breast cancer model: an in vivo study. Biol Trace Elem Res 2012, 149:22-28.